Mesenteric Vascular Insufficiency¶
Chapter 340 | Part 10: Disorders of the Gastrointestinal System · Part 10 – Gastrointestinal Disorders · Chapter 340
Key Clinical Points¶
- Pain out of proportion to physical examination is the hallmark clinical feature of acute mesenteric ischemia (AMI).
- Griffith's and Sudeck's points are critical colonic watershed areas and common sites for ischemia.
- Mortality in AMI remains high, between 50% and 80%.
- A negative duplex scan virtually precludes the diagnosis of mesenteric ischemia.
- Chronic mesenteric ischemia (CMI) is characterized by 'intestinal angina' due to atherosclerotic disease of the SMA or celiac artery.
- Acute mesenteric ischemia (AMI) is primarily embolic (50%) or thrombotic (25–30%).
- Nonocclusive mesenteric ischemia (20% of cases) is often triggered by acute hemodynamic instability.
- Mesenteric venous thrombosis (<10% of cases) is typically associated with hypercoagulable states.
- Timeliness of diagnosis and treatment is the primary determinant of survival in acute intestinal ischemia.
- Retrograde open mesenteric stenting (ROMS) is a hybrid approach for complex anatomical scenarios where standard methods are not feasible.
1. DEFINITION & OVERVIEW¶
• Intestinal Ischemia: Splanchnic perfusion fails to meet the metabolic demands of the intestines, resulting in ischemic tissue injury.
• Epidemiology: ◦ Incidence: 2–3 people per 100,000. ◦ Trend: Increasing incidence in the aging population.
• Chronic Mesenteric Ischemia (CMI): ◦ Definition: Failure to achieve normal postprandial hyperemic intestinal blood flow. ◦ Pathophysiology: Imbalance between supply and demand of oxygen metabolites; similar to cardiac angina. ◦ Etiology: Significant atherosclerotic disease leading to narrowing of the SMA and/or celiac artery. ◦ Clinical Course: Symptoms typically last 6–12 months.
• Acute Mesenteric Ischemia (AMI): ◦ Definition: Occurrence of an abrupt cessation of mesenteric blood flow, usually embolic or thrombotic in nature. ◦ Embolism: ~50% of cases; typically involves the mid to distal SMA. → Etiologies include atrial fibrillation, recent myocardial infarction, soft atherosclerotic plaque, infective endocarditis, valvular heart disease, and recent cardiac/vascular catheterization. ◦ Thrombosis: 25–30% of cases; occurs at sites of severe atherosclerotic narrowing (SMA and celiac artery).
• Nonocclusive Mesenteric Ischemia: ◦ Prevalence: 20% of cases. ◦ Mechanism: Disproportionate mesenteric vasoconstriction (arteriolar vasospasm) during acute hemodynamic instability. ◦ High-Risk Patients: Age >50, especially those with MI, CHF, aortic insufficiency, or renal/liver disease undergoing cardiovascular surgery. ◦ Triggers: Hypovolemia, shock, and use of vasoconstrictive agents (e.g., digoxin, α-adrenergic agonists, cocaine).
• Mesenteric Venous Thrombosis: ◦ Prevalence: <10% of cases. ◦ Etiology: Hypercoagulable states (Factor V Leiden, prothrombin mutation, protein S deficiency, protein C deficiency, antithrombin deficiency, antiphospholipid syndrome) or acquired thrombophilia (malignancies, hematologic disorders, oral contraceptives). ◦ Clinical Feature: May present with chronic diarrhea.
2. ETIOLOGY & PATHOPHYSIOLOGY¶
• Anatomy of Supply: ◦ Primary vessels: Celiac artery, SMA, and IMA. ◦ Collateralization: Extensive between major trunks; arc of Riolan connects SMA and IMA systems. ◦ Splanchnic Circulation: Can receive up to 30% of cardiac output.
• Watershed Areas: ◦ Griffith's point: Located at the splenic flexure; common site for colonic ischemia. ◦ Sudeck's point: Located at the descending/sigmoid colon; common site for colonic ischemia.
• Occlusive Ischemia Mechanism: ◦ Embolus: >75% of cases originate from the heart; typically lodge in the SMA just distal to the origin of the middle colic artery. ◦ Chronic: Requires progression of stenosis in two of the three major vessels; involvement of the SMA is most worrisome.
• Nonocclusive Ischemia Mechanism: ◦ Arteriolar vasospasm in response to severe physiologic stress (e.g., shock). ◦ Progression: Early mucosal stress ulceration → full-thickness injury.
3. CLINICAL FEATURES¶
• Chronic Mesenteric Ischemia (CMI): ◦ Presentation: Insidious onset; recurrent episodes of acute dull, crampy, postprandial epigastric pain ("intestinal angina"). ◦ Patient Behavior: Fear of eating → weight loss. ◦ Physical Exam: Malnourished patient with signs of atherosclerosis.
• Acute Mesenteric Ischemia (AMI): ◦ Presentation: Non-specific; requires high index of suspicion. ◦ Hallmark: Severe, acute, nonremitting abdominal pain out of proportion to physical findings (95% of cases). ◦ Associated Symptoms: ◦ Nausea (44%) ◦ Vomiting (35%) ◦ Diarrhea (35%) ◦ Blood per rectum (16%) ◦ Late Findings: Peritonitis and cardiovascular collapse.
• Etiology-Specific Features: ◦ Embolic: Older adults with AFib, prior embolic events, or recent infective endocarditis. ◦ Thrombotic: Patients with pre-existing CMI and acute occlusion at atherosclerotic sites.
4. DIFFERENTIAL DIAGNOSIS¶
• Primary Goal: Rule out gastrointestinal malignancies. ◦ Diagnostic Modalities: Esophagogastroduodenoscopy, colonoscopy, abdominal CT scan, and abdominal ultrasound.
5. INVESTIGATIONS & DIAGNOSIS¶
• Duplex Ultrasound: ◦ Role: Screening tool for mesenteric vessels. ◦ Findings: High peak velocity in SMA → ~80% positive predictive value (PPV) for ischemia. ◦ Requirement: Must be performed while fasting to avoid bowel gas interference and ensure proper assessment of vasodilation response. ◦ Critical Rule: A negative duplex scan virtually precludes the diagnosis of mesenteric ischemia.
• Computed Tomography Angiography (CTA): ◦ Role: Gold standard for assessing atherosclerotic disease of aortic/visceral vessels and bowel. Note: Use 1-mm or thinner cuts to detect arterial occlusive disease. ◦ Venous Phase: Used specifically to diagnose mesenteric vein thrombosis.
• Additional Modalities: ◦ ECG, Echocardiogram, Esophagogastroduodenoscopy, Colonoscopy.
• Diagnostic Algorithm: 1. Clinical Suspicion: High index of suspicion from history/physical exam despite normal labs. 2. Imaging: → Duplex Ultrasound (Screening) → CTA (Gold Standard) → CT Venous Phase (for venous thrombosis) 3. Intervention Decision: → If ischemia suspected → Consult surgical service. → If CTA confirms acute embolic SMA occlusion → Do not delay surgical exploration.
6. MANAGEMENT & TREATMENT¶
• Chronic Mesenteric Ischemia (CMI): 1. Medical Management: Stop smoking; initiate antiplatelet and lipid-lowering medications. 2. Evaluation: Full cardiac and vascular evaluation before intervention. 3. Revascularization: Individualized based on anatomy/comorbidities. ◦ Endovascular: Targeted vessel treatment with visceral stents (SMA is key determinant). ◦ Open Surgery: For cases with severe calcification, long lesions, small diameter, or failed endovascular attempts.
• Acute Mesenteric Ischemia (AMI): 1. Immediate Medical: Heparin bolus → heparin drip; correct electrolytes; broad-spectrum antibiotics. 2. Surgical Goals: Resect compromised bowel, restore blood supply, preserve viable tissue. 3. Procedure Steps: ◦ Evaluate entire length of small/large bowel from ligament of Treitz. ◦ Locate SMA (typically at mesocolon of transverse colon). ◦ Perform transverse arteriotomy → remove embolus with Fogarty catheter (retrograde and antegrate) → restore flow. ◦ Resect nonviable bowel.
• Mesenteric Venous Thrombosis: 1. Medical: Anticoagulation, resuscitation, broad-spectrum antibiotics. 2. Workup: Hypercoagulable workup. 3. Precautions: Avoid vasoconstrictors; support cardiac output.
• Nonocclusive Mesenteric Ischemia: 1. Vasospasm Management: Resuscitation, broad-spectrum antibiotics, avoid vasoconstrictors, intraarterial vasodilators. 2. Hypoperfusion Management: Resuscitation, broad-spectrum antibiotics, support cardiac output; assess viability → resect dead bowel.
• Table 340-1 (Management of Acute Intestinal Ischemia): Summary of management based on condition: ◦ Arterio-occlusive: CTA/Duplex for diagnosis; Early laparotomy/Embolectomy; Anticoagulation, Cardioversion, Thrombectomy, Broad-spectrum antibiotics. ◦ Venous Thrombosis: CTA with venous phase; Anticoagulation, Resuscitation, Hypercoagulable workup; Avoid vasoconstrictors. ◦ Nonocclusive: CT for diagnosis; Intraarterial vasodilators (for vasospasm); Resuscitation/Support cardiac output (for hypoperfusion).
Surgical Interventions¶
• Embolectomy: Removal of embolus with Fogarty catheter (retrograde and antegrate) to restore flow. • Vascular Bypass: ◦ Antegrade: From supraceliac aorta. ◦ Retrograde: From common or external iliac arteries using synthetic or autogenous graft. • Retrograde Open Mesenteric Stenting (ROMS): ◦ Definition: Hybrid approach combining aspects of traditional open surgical bypass and percutaneous endovascular therapy. ◦ Indications: When conventional endovascular or open surgical approaches are not feasible/successful; presence of significant stenosis/occlusion; need for immediate direct visualization/resection due to necrosis or perforation. ◦ Advantages: Faster operative times than traditional bypass; avoids placing prosthetic material in potentially contaminated peritoneal cavities.
7. PROGNOSIS & COMPLICATIONS¶
• Mortality: AMI mortality 50–80%. • Key Success Factor: Timeliness of diagnosis and treatment. • Complications: Peritonitis, cardiovascular collapse, bowel necrosis, perforation.
8. SPECIAL CONSIDERATIONS¶
• High-Risk Populations: ◦ Patients with AFib, prior embolic events, or infective endocarditis (higher risk of embolic ischemia). ◦ Patients >50 with MI, CHF, aortic insufficiency, renal/liver disease during cardiovascular surgery (high risk for nonocclusive ischemia). ◦ Younger, healthier patients: May benefit from open revascularization as long-term advantages may outweigh perioperative risks.
9. KEY PEARLS & CLINICAL TRAPS¶
• Hallmark: Pain out of proportion to physical exam. • Anatomy: Griffith's and Sudeck's points are critical colonic watershed areas. • Mortality: High (50–80%) in acute presentation. • Imaging Rule: A negative duplex scan virtually precludes the diagnosis of mesenteric ischemia. • Survival Factor: Timeliness of diagnosis/treatment is the most significant indicator of survival. • Hybrid Approach: ROMS is indicated when conventional endovascular or open surgical approaches are not feasible.
Reference Tables¶
TABLE 340-1 Overview of the Management of Acute Intestinal Ischemia CONDITION Arterio-occlusive mesenteric ischemia 1.…¶
Harrison's 22e, p.2588
| CONDITION | KEY TO EARLY DIAGNOSIS |
TREATMENT OF UNDERLYING CAUSE |
TREATMENT OF SPECIFIC LESION | TREATMENT OF SYSTEMIC CONSEQUENCE |
|---|---|---|---|---|
| Arterio-occlusive mesenteric ischemia 1. Arterial embolus |
Computed tomography angiography (CTA) Early laparotomy |
Anticoagulation Cardioversion Thrombectomy Broad-spectrum antibiotics |
Laparotomy Embolectomy Assess viability and resect nonviable bowel |
Anticoagulation Resuscitation Broad-spectrum antibiotics Emergent surgical intervention Assessment of bowel |
| 2. Arterial thrombosis | Duplex ultrasound CTA |
Anticoagulation Broad-spectrum antibiotics Resuscitation |
Endovascular approach: thrombolysis, angioplasty, and stenting Endarterectomy/thrombectomy or vascular bypass Assess viability and resect nonviable bowel |
Anticoagulation Resuscitation Broad-spectrum antibiotics Emergent surgical intervention Assessment of bowel |
| CTA with venous phase | Anticoagulation Resuscitation |
Anticoagulation Hypercoagulable workup |
||
| Nonocclusive mesenteric ischemia |
Vasospasm: Hypoperfusion: CT |
Resuscitation Support cardiac output Avoid vasoconstrictors Broad-spectrum antibiotics |
Vasospasm Intraarterial vasodilators Hypoperfusion Assess viability and resect dead bowel |
Resuscitation Broad-spectrum antibiotics Support cardiac output Avoid vasoconstrictors |